Official Best of SABCS(R) News - 2020 SABCS(R) Highlights Coverage
The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS(R)) is just one week away!
Register now to the Official Best of SABCS(R) News 2020 program to get a daily update on the most relevant advances in breast cancer.
Encore Medical Education (www.encoremeded.com) will publish a new edition of the Official Best of SABCS(R) News from the 2020 San Antonio Breast Cancer Symposium (SABCS(R)) starting December 9, 2020.
Registration is now open to access the Official Best of SABCS(R) News. Registration is open to health care professionals at no fee at www.bestofsabcsnews.com . The first video news from the most relevant abstracts will be published starting December 9, 2020 at 4:00 pm CDT (GMT -6 hours).
The Official SABCS(R) News English website ( www.bestofsabcsnews.com ) will include daily expert video summaries with original presentation slides of the most significant clinical trials presented each day. World-renowned experts such as Drs. Kaklamani, Rugo, and Gradishar among others will present the key takeaways from the major trials from #SABCS20 including:
- First results from PENELOPE-B
- Final invasive disease-free survival analysis of monarchE
- Results of the prospective multicenter RISAS trial
- Correlative biomarker analysis of intrinsic subtypes and efficacy across the MONALEESA Phase III studies
- Results from KEYNOTE-355
- Results from CONTESSA
- Analysis of SWOG S9313 adjuvant trial
- And many others…
Additional SABCS(R) News language versions will be accessible on https://www.bestofsabcs.com/best-of-sabcs-news/:
- The Official SABCS(R) News program in German
- The Official SABCS(R) News program in Japanese
About Best of SABCS(R) programs
The San Antonio Breast Cancer Symposium(R), now in its 43rd year, is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known for presenting the latest breast cancer data from all over the world.
Best of SABCS(R) programs offer professionals the opportunity to experience and discuss the most current research and advances in the field of breast cancer with colleagues and key opinion leaders with access to the original presentations and posters.
For information on Best of SABCS(R) opportunities, please contact Encore Medical Education LLC, the exclusive agent of the SABCS(R) for the dissemination of Symposium content internationally, at [email protected]
Photo: https://mma.prnewswire.com/media/792198/Encore_Medical_Education_SABCS_Logo.jpg
ข่าวbreast cancer+Best of SABCSวันนี้
Encore Medical Education announces publication of the Official Best of SABCS(R) News Highlights summarizing key trial results from the 2022 SABCS(R)
Best of SABCS(R) News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS(R) News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS(R) ) starting December 7th. This official SABCS(R) News Highlights program reached more than 5,000 health
Official Best of SABCS(R) News - 2020 SABCS(R) Highlights Coverage
The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS(R)) is just one week away! Register now to the Official Best of SABCS(R) News 2020 program to get a daily update on the most relevant advances in breast cancer. Encore...
AXA Strengthens Cancer Awareness and Prevention Efforts in Thailand
—
Cancer remains one of the most pressing health challenges in Thailand, with over 180...
Is it really acceptable? 22 women in Thailand lose their lives to breast cancer each day. Thanyarak Foundation x True invite you to reduce the risk with 'Breast must be checked'—can't wait, the sooner, the better
BDMS Wellness Clinic Joins Forces with Bangkok Cancer Hospital Wattanosothto Advocate for the "Voice of Care for Breast Cancer,"
—
BDMS Wellness Clinic Jo...
BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention
—
Bangkok Dusit Medical Services Public Company Limited (BDMS), a...
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection , securing exclusive commercialization licensing and supply of...Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications
KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor...Menarini Group Announces New Data on ORSERDU(R) (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS(R) (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition
- Data spans eleven presentations across both solid tumors and hematologic malign...
Krungsri supports Breast Foundation in screening breast cancer for disadvantaged women for 14th year
—
Mr. Poonsit Wongthawatchai (left), Krungsri Executi...